Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis

Journal of Investigative Medicine

Volumn 59, Issue 3, 2011, Pages 593-598

  Lv, Hao Zhe ^a,b   Lin, Tao ^a,c   Xia, Li Ping ^a   Shen, Hui ^a   Zhu, Xiang Yang ^a   Zhang, Jin Tao ^a   Xiao, Wei Guo ^a   Lu, Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Daqing Oilfield General Hospital   (China)

^c Department of Rheumatology and Immunology   (China)

Author keywords

Rheumatoid arthritis; Single nucleotide of polymorphisms; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GENOMIC DNA; RHEUMATOID FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960088981     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31820c9e21     Document Type: Article

References (27)

1. Kurreeman FA, Padyukov L, Marques RB, et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 2007;4(9):e278.
2. Plenge RM, Padyukov L, Remmers EF, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in 94,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77(6):1044-1060. (Pubitemid 41698524)
3. Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford). 2008;47(4):399-402.
4. Koch AE. The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis. 2000;59(suppl 1):i65Yi71.
5. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res. 2002;4(suppl 3):S81YS90.
6. Lee SS, Joo YS, Kim WU, et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001;19(3):321-324.
7. Sone H, Sakauchi M, Takahashi A, et al. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity. Life Sci. 2001;69(16):1861-1869. (Pubitemid 32835268)
8. Ballara S, Taylor PC, Reusch P, et al. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum. 2001;44(9):2055-2064. (Pubitemid 33644048)
9. McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 2002;62(12):3369-3372. (Pubitemid 34651380)
10. Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer. 2003;106(4):468-471. (Pubitemid 36966201)
11. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol. 2002;13(1):260-264. (Pubitemid 34042036)
12. Rueda B, González-Gay MA, López-Nevot MA, et al. Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. Hum Immunol. 2005;66(8):864-868. (Pubitemid 41416530)
13. Han SW, Kim GW, Seo JS, et al. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford). 2004;43(9):1173-1177. (Pubitemid 39232824)
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-324. (Pubitemid 18091653)
15. Radomska-Lesniewska DM, Skopinska-Rozewska E, Jankowska-Steifer E, et al. N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients. Pharmacol Rep. 2010;62(1):131-138.
16. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis. 1996;55(2):116-121.
17. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978-989. (Pubitemid 32289743)
18. Butt C, Lim S, Greenwood C, et al. FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet Disord. 2007;8:1.
19. Fearon U, Reece R, Smith J, et al. Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci. 1999;878:619-621. (Pubitemid 29353629)
20. Maeno N, Takei S, Imanaka H, et al. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol. 1999;26(10):2244-2248. (Pubitemid 29487025)
21. Fava RA, Olsen NJ, Spencer-Green G, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med. 1994;180(1):341-346. (Pubitemid 24181082)
22. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994;152(8):4149-4156. (Pubitemid 24111088)
23. Rothschild BM, Masi AT. Pathogenesis of rheumatoid arthritis: a vascular hypothesis. Semin Arthritis Rheum. 1982;12(1):11-31. (Pubitemid 12016829)
24. RennerW, Kotschan S, Hoffmann C, et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37(6):443-448. (Pubitemid 32037619)
25. Quandt K, Frech K, Karas H, et al. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995 Dec 11;23(23):4878-4884. (Pubitemid 3008389)
26. Hadaschik D, Hinterkeuser K, Oldak M, et al. The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol. 2003;77(9):5253-5265. (Pubitemid 36460939)
27. Mazumder B, Seshadri V, Fox PL. Translational control by the 3'-UTR: the ends specify the means. Trends Biochem Sci. 2003;28(2):91-98. (Pubitemid 36165138)